337917-94-9

Basic information

• Product Name: Pyridine, 2,6-dibromo-4-phenyl-
• CAS NO: 337917-94-9
• Molecular Formula: C11H7Br2N
• Molecular Weight: 312.991
• Mol File: 337917-94-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Pyridine, 2,6-dibromo-4-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 2,6-dibromo-4-phenyl-(337917-94-9)
• EPA Substance Registry System: Pyridine, 2,6-dibromo-4-phenyl-(337917-94-9)

Safety Data

• Hazardous Substances Data: 337917-94-9(Hazardous Substances Data)

Upstream product

• 39771-34-1 4-amino-2,6-dibromopyridine 
• 71-43-2 benzene 
• 1160184-14-4 2,6-dibromo-4-iodopyridine 
• 98-80-6 phenylboronic acid 
• 98027-81-7 2,6-dibromo-4-nitro-pyridine 1-oxide 
• 25373-69-7 2,6-dibromopyridin N-oxide 
• 626-05-1 2,6-Dibromopyridine 

Downstream Products

• 1291081-25-8 2-bromo-4,6-diphenylpyridine 
• 128736-34-5 2-bromo-6-(methylthio)-4-phenylpyridine 
• 337917-98-3 tetraethyl N,N,N',N'-[2,6-bis(3'-bromomethyl-1'-pyrazolyl)-4-phenylpyridine] tetrakis acetate 
• 337917-99-4 N,N,N',N'-[2,6-bis(3'-bromomethyl-1'-pyrazolyl)-4-phenylpyridine] tetrakis(acetic acid) 
• 337917-96-1 2,6-bis(3'-hydroxymethyl-1'-pyrazolyl)-4-phenylpyridine 
• 337917-97-2 2,6-bis(3'-bromomethyl-1'-pyrazolyl)-4-phenylpyridine 
• 337917-95-0 2,6-bis(3'-methoxycarbonyl-1'-pyrazolyl)-4-phenylpyridine 

Relevant articles and documents

TYK-2 INHIBITOR

Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating a disease associated with the undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same.

Heteroanthracene pyrene compounds and OLED (organic light emitting diode) based on same

The invention provides heteroanthracene pyrene compounds and an OLED (organic light emitting diode) based on the same, and belongs to the technical field of organic photoelectric materials. The technical problems that the organic photoelectric materials have poor light emitting properties such as low light emitting efficiency, higher driving voltage, short service life and the like in the prior art are solved. Compared with the prior art, the OLED based on the heteroanthracene pyrene compounds has the advantages that light emitting properties are improved, and the compounds are excellent OLED materials.

Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by inhibition of Syk kinase and/or Janus kinases.